Remepy (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- May 01, 2024
- Vertical
- Pharmaceuticals / Digital Therapeutics
- Funding URL
- View Funding Page
- Funding Amount:
- $15,000,000
Company Info
- Founders
- Michal Tsur
- Company Description
- Remepy is biotechnology research pioneering hybrid drugs.
- Market
- Oncology, MCI, and Parkinson's Disease
- Location
- New York, NY, USA
- Coinvestors
- Firstime Venture Capital, NFX, PsyMed Ventures, Supernode Ventures, Vine Ventures